Patients with psoriatic arthritis may show differences in their clinical and genetic profiles depending on their age at psoriasis onset

Clin Exp Rheumatol. 2012 Jul-Aug;30(4):476-80. Epub 2012 Aug 29.

Abstract

Objectives: The age of psoriasis onset has an important impact on the clinical expression and heritability of psoriasis. Psoriasis characteristics according to the age at disease onset have been extensively studied. However, the impact of the age of psoriasis onset on psoriatic arthritis (PsA) features has not been analysed in depth. The aim of the present paper is to analyse whether the age of psoriasis onset may have an impact on the clinical and genetic characteristics in a cohort of PsA patients.

Methods: The study included 110 PsA patients classified in accordance with the CASPAR criteria. Patients were divided into early (onset age <30 years) and late (onset age >30 years) onset psoriasis, and clinical features were studied in accordance to this stratification. Distribution of several genes within the MHC region were analysed in accordance with the prior stratification, and their frequencies compared to that of 110 healthy matched blood donors.

Results: Compared to patients with late-onset disease, PsA patients with early-onset psoriasis showed more frequently: a longer psoriasis-arthritis latency period (9.9±6 years vs. 3.8±4 years, p=0.0001), a positive family history of disease (60.3% vs. 20.5%, OR 6.1, 95% CI: 2.5-15.0, p=0.0001), severe psoriasis (PASI 8.2±4 vs. 3.6±2.2, p=0.0001), clinical enthesitis (37.7% vs. 22.4%, OR 2.09, 95% CI: 0.9-4.9, p=0.08), and oligoarthritis (47.5% vs. 28.6%, OR 2.26, 95% CI: 1.02-5.02, p=0.04). MICA-A9 was associated with susceptibility in both early-onset (60.7% vs. 30%, p=0.0002) and late-onset patients (59.2% vs. 30%, p=0.0008). However, HLA-Cw*0602 was significantly increased in patients with early-onset psoriasis (73.8% vs. 17%, p<0.0001), whereas the allele 384 of the microsatellite C1_4_4, located 34 kb telomeric to HLA-C locus, was increased only in late-onset cases (49% vs. 21%, p=0.001).

Conclusions: Clinical and genetic features of PsA may differ depending on the age at psoriasis onset. This type of stratification should be considered in future genetic and epidemiological studies of PsA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Distribution
  • Age of Onset
  • Arthritis, Psoriatic / epidemiology*
  • Arthritis, Psoriatic / genetics*
  • Arthritis, Psoriatic / immunology
  • Cohort Studies
  • Female
  • Genetic Predisposition to Disease / epidemiology
  • Genetic Predisposition to Disease / genetics
  • Glycoproteins / genetics
  • Glycoproteins / immunology
  • HLA-C Antigens / genetics*
  • HLA-C Antigens / immunology
  • Histocompatibility Antigens Class I / genetics
  • Histocompatibility Antigens Class I / immunology
  • Histocompatibility Testing
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Male
  • Microsatellite Repeats / genetics
  • Middle Aged
  • Octamer Transcription Factor-3 / genetics
  • Octamer Transcription Factor-3 / immunology
  • Polymorphism, Genetic / genetics
  • Polymorphism, Genetic / immunology
  • Risk Factors
  • Telomere / genetics

Substances

  • CDSN protein, human
  • Glycoproteins
  • HLA-C Antigens
  • HLA-C*06:02 antigen
  • Histocompatibility Antigens Class I
  • Intercellular Signaling Peptides and Proteins
  • MHC class I-related chain A
  • Octamer Transcription Factor-3
  • POU5F1 protein, human